UVE shareholder trust (NYSE: UVE) plans sale of 25,000 common shares
Rhea-AI Filing Summary
A shareholder identified as the Stephen Donaghy Trust has filed a Form 144 notice relating to common shares of UVE. The filing covers an intended sale of 25,000 common shares through Wells Fargo Clearing Services on the NYSE around 12/30/2025, with an aggregate market value of 844,398.16. These 25,000 shares were originally acquired on 11/15/2018 via an open market purchase paid in cash. The notice also reports that the Stephen Donaghy Trust sold 25,000 common shares of UVE on 12/29/2025 for gross proceeds of 851,779.94. By signing, the seller represents that they are not aware of any undisclosed material adverse information about UVE’s operations.
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for UVE disclose?
The Form 144 discloses that the Stephen Donaghy Trust intends to sell 25,000 common shares of UVE and provides details about the size, timing, and method of the planned sale.
What assurance does the seller give about information on UVE?
By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about UVE’s current or prospective operations that has not been publicly disclosed.